Skip to content

Topography-guided LASIK Surgery

A Prospective Evaluation of Topography-guided LASIK Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03292419
Enrollment
30
Registered
2017-09-25
Start date
2018-06-01
Completion date
2022-03-31
Last updated
2022-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The investigators are analyzing outcomes of topography-guided LASIK surgery in participants with myopia and myopic astigmatism

Detailed description

The investigators are analyzing outcomes of topography-guided LASIK surgery in participants with myopia and myopic astigmatism. The investigators will be monitoring changes in anterior segment optical coherence tomography epithelial thickness maps. The investigators will compare preoperative maps to postoperative maps at one, three, six and twelve months. In addition, the investigators will measure changes in epithelial maps from postoperative month through twelve months to help understand what is happening to the corneal epithelium to try to explain why UDVA and CDVA improves over time

Interventions

LASIK surgery

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

N0ne

Intervention model description

Topography guided

Eligibility

Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects age 18 and older with healthy eyes. Nearsightedness between -0.50 diopters and -8.00 diopters. * Subjects with up to 3.00 diopters of astigmatism. * Subjects with a spherical equivalent of up to -9.00 diopters.

Exclusion criteria

* Subjects under the age of 18. * Subjects with excessively thin corneas. * Subjects with topographic evidence of keratoconus. * Subjects with ectatic eye disorders. * Subjects with autoimmune diseases. * Subjects who are pregnant or nursing. * Subjects with more than 3.00 diopters of astigmatism

Design outcomes

Primary

MeasureTime frameDescription
Epithelial thickness maps12 monthsChanges in anterior segment optical coherence tomography epithelial thickness maps.

Secondary

MeasureTime frameDescription
Uncorrected distance visual acuity12 monthsUncorrected distance visual acuity (UDVA)
Quality of Vision12 monthsPatient reported outcomes questionnaire
Predictability12 monthsPercentage of eyes within +/-0.25, 0.50 and 1.00 diopter of the intended correction
Changes in corrected visual acuity12 monthsCorrected distance visual acuity (CDVA)
Residual astigmatism levels after surgery12 monthsVector analysis of astigmatic outcomes
Change in refraction over time12 monthsChange in spherical equivalent over time
Contrast visual acuity12 months5 and 25% ETDRS contrast acuity

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026